CN1232641C - Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂 - Google Patents

Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂 Download PDF

Info

Publication number
CN1232641C
CN1232641C CNB998041513A CN99804151A CN1232641C CN 1232641 C CN1232641 C CN 1232641C CN B998041513 A CNB998041513 A CN B998041513A CN 99804151 A CN99804151 A CN 99804151A CN 1232641 C CN1232641 C CN 1232641C
Authority
CN
China
Prior art keywords
rap
protein
rip
cell
people
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998041513A
Other languages
English (en)
Chinese (zh)
Other versions
CN1295614A (zh
Inventor
大卫·沃勒克
安德烈·科瓦连科
马歇尔·S·霍维茨
李永安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Albert Einstein College of Medicine
Original Assignee
Yeda Research and Development Co Ltd
Albert Einstein College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12375898A external-priority patent/IL123758A0/xx
Application filed by Yeda Research and Development Co Ltd, Albert Einstein College of Medicine filed Critical Yeda Research and Development Co Ltd
Publication of CN1295614A publication Critical patent/CN1295614A/zh
Application granted granted Critical
Publication of CN1232641C publication Critical patent/CN1232641C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNB998041513A 1998-03-19 1999-03-18 Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂 Expired - Fee Related CN1232641C (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL123758 1998-03-19
IL12375898A IL123758A0 (en) 1998-03-19 1998-03-19 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
IL126024 1998-09-01
IL12602498A IL126024A0 (en) 1998-03-19 1998-09-01 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
CA002323637A CA2323637A1 (en) 1998-03-19 1999-03-18 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100886916A Division CN100557021C (zh) 1998-03-19 1999-03-18 Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂

Publications (2)

Publication Number Publication Date
CN1295614A CN1295614A (zh) 2001-05-16
CN1232641C true CN1232641C (zh) 2005-12-21

Family

ID=39598416

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998041513A Expired - Fee Related CN1232641C (zh) 1998-03-19 1999-03-18 Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂

Country Status (24)

Country Link
US (1) US6734174B1 (xx)
EP (1) EP1062336B1 (xx)
JP (1) JP4351389B2 (xx)
KR (1) KR100748293B1 (xx)
CN (1) CN1232641C (xx)
AT (1) ATE318310T1 (xx)
AU (1) AU760900B2 (xx)
BG (2) BG64990B1 (xx)
BR (1) BR9909659A (xx)
CA (2) CA2625284A1 (xx)
DE (1) DE69929958T2 (xx)
DK (1) DK1062336T3 (xx)
EA (1) EA004062B1 (xx)
EE (1) EE200000538A (xx)
ES (1) ES2258838T3 (xx)
HK (1) HK1034995A1 (xx)
HU (1) HUP0101612A3 (xx)
IL (1) IL126024A0 (xx)
NO (1) NO327854B1 (xx)
NZ (2) NZ525566A (xx)
PL (1) PL200763B1 (xx)
PT (1) PT1062336E (xx)
SK (1) SK285804B6 (xx)
WO (1) WO1999047672A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189832B1 (en) * 1998-08-20 2007-03-13 The Regents Of The University Of California Gamma subunit of cytokine responsive IκB-alpha kinase complex and methods of using same
US7745579B1 (en) 1998-09-01 2010-06-29 David Wallach Inhibitor of NF-KB activation
MXPA04000134A (es) 2001-06-26 2005-06-06 Abgenix Inc Anticuerpos para ligandos de osteoprotegerina.
US7521534B1 (en) * 2003-03-03 2009-04-21 The University Board Of Regents Of Texas System IKK gamma gene products and methods for making and using same
CN1886148B (zh) * 2003-09-24 2013-01-02 巴斯德研究院 被设计用于破坏NEMO寡聚化的肽对NF-kB活化的选择性抑制
EP2492281B1 (en) * 2009-10-19 2018-04-11 HanAll Biopharma Co., Ltd. Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
CN102399819B (zh) * 2011-08-24 2013-06-19 西北农林科技大学 一种质粒型腺病毒载体pAd-NRIP1及其构建方法
DE102011115480A1 (de) * 2011-10-06 2013-04-11 Biostep Gmbh Substrat und Vorrichtung zur Chemilumineszenzdetektion
EA201791289A1 (ru) 2014-12-11 2017-12-29 Президент Энд Феллоуз Оф Гарвард Колледж Ингибиторы клеточного некроза и связанные с ними способы

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
IL94039A (en) * 1989-08-06 2006-09-05 Yeda Res & Dev Antibodies to tbp - 1 and their use
CA2017025C (en) * 1989-05-18 2008-07-22 David Wallach Tumor necrosis factor binding protein ii, its purification and antibodies thereto
EP0813419B8 (en) * 1995-02-22 2005-08-24 Yeda Research & Development Company, Ltd. Modulators of regulatory proteins
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein
AU7457796A (en) * 1995-10-23 1997-05-15 Tularik Inc. Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays
JP2000512494A (ja) 1996-05-29 2000-09-26 ジェンザイム・コーポレーション 細胞増殖調節遺伝子

Also Published As

Publication number Publication date
ES2258838T3 (es) 2006-09-01
SK13762000A3 (sk) 2001-03-12
HUP0101612A2 (hu) 2004-01-28
IL126024A0 (en) 1999-05-09
PL200763B1 (pl) 2009-02-27
NO20004649D0 (no) 2000-09-18
SK285804B6 (sk) 2007-08-02
AU2954599A (en) 1999-10-11
ATE318310T1 (de) 2006-03-15
BR9909659A (pt) 2000-11-21
US6734174B1 (en) 2004-05-11
NZ525566A (en) 2004-12-24
PL343262A1 (en) 2001-07-30
BG65684B1 (bg) 2009-06-30
CA2323637A1 (en) 1999-09-23
EA004062B1 (ru) 2003-12-25
KR20050107527A (ko) 2005-11-11
NO327854B1 (no) 2009-10-05
HUP0101612A3 (en) 2005-03-29
JP2002506644A (ja) 2002-03-05
BG104769A (en) 2001-04-30
DE69929958D1 (de) 2006-04-27
NO20004649L (no) 2000-10-30
EP1062336B1 (en) 2006-02-22
AU760900B2 (en) 2003-05-22
EE200000538A (et) 2002-04-15
PT1062336E (pt) 2006-05-31
KR100748293B1 (ko) 2007-08-09
CN1295614A (zh) 2001-05-16
DE69929958T2 (de) 2006-11-23
HK1034995A1 (en) 2001-11-09
EP1062336A1 (en) 2000-12-27
CA2625284A1 (en) 1999-09-23
NZ506776A (en) 2003-08-29
DK1062336T3 (da) 2006-05-29
WO1999047672A1 (en) 1999-09-23
JP4351389B2 (ja) 2009-10-28
BG109537A (en) 2007-11-30
EA200000961A1 (ru) 2001-04-23
BG64990B1 (bg) 2006-11-30

Similar Documents

Publication Publication Date Title
CN1197966C (zh) 肿瘤坏死因子受体相关因子的调节剂、及其制备和用途
CN1310942C (zh) 校正基因
CN1105725C (zh) Fas/ap01受体功能的调节物
CN1152937A (zh) Tnf/ngf超家族受体和可溶性寡聚tnf/ngf超家族受体的调节剂
CN1836048A (zh) 可转导的dna结合蛋白
CN1155402C (zh) 一种抑制信号－传导蛋白和glgf(pdz/d hr)区域之间相互作用的化合物及其应用
CN1739788A (zh) Trip－br功能的调节和治疗增殖性紊乱的方法
CN1232641C (zh) Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂
CN1250717C (zh) 金属蛋白酶家族中的人酶
CN1223608C (zh) 与半胱天冬蛋白酶－8相互作用的蛋白
CN1189564C (zh) Tnf/ngf受体家族中受体功能的调节剂
CN1684977A (zh) 多肽与编码这些多肽的核酸和它们用于预防、诊断或治疗肝脏失调和上皮癌的用途
CN1254377A (zh) 哺乳动物chk1效应物细胞周期关卡蛋白激酶材料与方法
CN1148446C (zh) 与mort-1和mach结合的多肽及其dna序列、生产方法、药物组合物和用途
CN1259165A (zh) 胞内发炎、细胞死亡和细胞存活通道的调节剂
CN1630664A (zh) 胱冬酶－8结合蛋白及其制备和使用
CN1283793C (zh) 具有骨骼肌刺激活性和免疫调节作用的趋化素样因子超家族
CN1057096C (zh) 蛋白质pl40多肽及编码该多肽的DNA
CN1249087C (zh) 新的人g蛋白偶联受体
CN1384878A (zh) Iren蛋白,其制备和应用
CN1743456A (zh) Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂
CN1177864C (zh) 在肝癌组织中具有表达差异的新的人蛋白及其编码序列
CN1875100A (zh) BACE455,人β－分泌酶的可变剪接变体
CN1932016A (zh) 影响sre活性的多核苷酸及其编码多肽和用途
CN1246457C (zh) 人tsc403基因和人ing1l基因

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20051221

Termination date: 20100318